Halozyme Therapeutics (HALO) Assets (2010 - 2026)
Halozyme Therapeutics (HALO) reported Assets of $2.58 billion for Q2 2026, up 25.5% from $2.05 billion a year earlier but down 3.6% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics posted Assets of $2.53 billion, up 22.4% from FY2024.
- Assets has a five-year compound annual growth rate of 34.2% (FY2020 to FY2025).
- By year, Assets came in at $2.06 billion in FY2024 (+19.1%), $1.73 billion in FY2023 (-5.9%), $1.84 billion in FY2022 (+66.7%) and $1.1 billion in FY2021 (+90.4%).
- Five-year quarterly Assets spans a low of $1.1 billion in Q4 2021 and a high of $2.67 billion in Q1 2026.
- Year over year, Assets has now increased in each of the last ten quarters, with growth averaging 16.1% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q3 2021 (growth of 126.2%); the low point was Q4 2023 (a decline of 5.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.67 billion (Q1 2026), $2.53 billion (Q4 2025) and $2.22 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Halozyme Therapeutics | 11.78 Bn | 10.02 Bn | 410.50 Mn | 3.47 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.47 Bn |
| Jun 30, 2026 | 2.58 Bn |
| Mar 31, 2026 | 2.67 Bn |
| Dec 31, 2025 | 2.53 Bn |
| Sep 30, 2025 | 2.22 Bn |
| Jun 30, 2025 | 2.05 Bn |
| Mar 31, 2025 | 2.20 Bn |
| Dec 31, 2024 | 2.06 Bn |
| Sep 30, 2024 | 2.12 Bn |
| Jun 30, 2024 | 1.97 Bn |
| Mar 31, 2024 | 1.84 Bn |
| Dec 31, 2023 | 1.73 Bn |
| Sep 30, 2023 | 1.89 Bn |
| Jun 30, 2023 | 1.81 Bn |
| Mar 31, 2023 | 1.70 Bn |
| Dec 31, 2022 | 1.84 Bn |
| Sep 30, 2022 | 1.86 Bn |
| Jun 30, 2022 | 1.78 Bn |
| Mar 31, 2022 | 1.16 Bn |
| Dec 31, 2021 | 1.10 Bn |
API Access
Halozyme Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();